Overview
Duffy isoimmunization in newborns occurs when maternal antibodies against fetal Duffy antigens cross the placenta, potentially leading to hemolytic disease of the newborn (HDN). This condition is rare but can cause severe anemia and other hematological complications in affected infants 1.Diagnosis
Maternal Screening: Identify Duffy antigen antibodies in maternal blood 1.
Fetal/Newborn Assessment: Evaluate for signs of hemolytic anemia including elevated bilirubin levels, decreased hemoglobin, and reticulocyte count 1.
Direct Antibody Testing: Perform direct antiglobulin test (DAT) on newborn blood samples to detect bound maternal antibodies 1.Management
Monitoring: Regular monitoring of hematological parameters including hemoglobin levels and bilirubin 1.
Phototherapy: Indicated for hyperbilirubinemia to prevent kernicterus 1.
Exchange Transfusion: Consider for severe anemia unresponsive to other interventions 1.Special Populations
Pregnancy: Focus on antenatal screening and monitoring for at-risk pregnancies 1.
Pediatrics: Early detection and management crucial for preventing complications in neonates 1.Key Recommendations
Perform routine antenatal screening for Duffy antibodies in pregnant women at risk 1 (Evidence: Expert opinion).
Routinely monitor newborn infants of Duffy isoimmunized mothers for signs of hemolytic anemia 1 (Evidence: Expert opinion).
Initiate phototherapy promptly for elevated bilirubin levels in affected newborns 1 (Evidence: Expert opinion).References
1 Herscowitz HB, Harold WW, Stavitsky AB. Immunochemical and immunogenic properties of a purified keyhold limpet haemocyanin. Immunology 1972. link